ACNT at a glance
ASCENT INDUSTRIES CO. (ACNT, SEC CIK 95953) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on August 26, 2026 and Form 4 insider filings as recently as September 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), ASCENT INDUSTRIES CO. (ACNT) reported revenue of $74.9 million (down 57.9% from FY2024) and net income of $867,000. Diluted EPS was $0.09.
- As of June 30, 2026, 19 institutional investment managers tracked by SignalX reported holding ASCENT INDUSTRIES CO. (ACNT) shares worth $27.3 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Mazzaferro Aldo John Jr on June 26, 2026 of 1,500 shares at $14.10 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $74.9M
- −57.9% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 19 funds
- $27.3M · −2 vs prior quarter
- Latest 8-K
- Aug 26, 2026
- Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Q2 revenue $25.7M, up $7.0M or 37.6% YoY
- Gross margin 21.6% vs 26.1% YoY; operating loss $0.3M vs $2.7M
- Specialty Chemicals operating income $0.6M vs $1.5M; Adjusted EBITDA margin 7.3% vs 13.6%
- Cash $28.1M; operating cash use $7.7M vs $8.9M; investing cash use $14.7M from Midwest Graphic Sales acquisition
- Tariffs, inflation, raw-material volatility and geopolitical conflicts potential near-term headwinds; capital spending up to $3.0M expected remainder of 2026
Risk Factors
- No Risk Factors section provided in the submitted filing excerpt
- No newly added, updated, regulatory, operational, competitive, or financial risks identifiable
- Share repurchases: 209,868 shares acquired at average $13.80 during the quarter
- Repurchase authorization: 1,492,941 shares remaining under 2.0 million-share program
- No defaults upon senior securities or insider trading-plan adoptions reported
AI summary of the ACNT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Investor presentation scheduled for August 26, 2026, providing management’s latest investor messaging
- Exhibit 99.1 contains Non-GAAP financial measures and required GAAP reconciliations
Item 2.02: Results of Operations and Financial Condition
- Q2 fiscal 2026 financial results released for quarter ended June 30, 2026
- Full operating metrics and management commentary available in Exhibit 99.1 press release
Item EX-99.1: Item EX-99.1
- Q2 net sales rose 37.6% to $25.7M, including $1.9M from Midwest Graphic Sales acquired May 4
- Adjusted EBITDA improved $1.8M to $1.5M, with margin reaching 5.7% versus negative 1.8% year over year
Item 1.01: Entry into a Material Definitive Agreement
- Credit facility amended July 17, 2026 following Midwest Graphic Sales and Sigma Coatings acquisition
- Newly formed Ascent Chemicals–MGS, LLC added as borrower and loan party
AI summaries of ACNT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ACNT
Don't miss the next ACNT filing
- Alerts as it files. A push when ACNT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ACNT, by share count.
- Ask anything. An AI agent that reads every ACNT filing and answers with sources.
ACNT alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Kitchen John Bryan | F | Sep 21, 2026 | 2,269 | $14.70 |
| Mazzaferro Aldo John Jr | Sell | Jun 26, 2026 | 1,500 | $14.10 |
| Mazzaferro Aldo John Jr | A | Jun 10, 2026 | 4,231 | $13.59 |
| Rosenzweig Benjamin L | A | Jun 10, 2026 | 4,415 | $13.59 |
| Giannantonio Carmen Joseph | A | Jun 10, 2026 | 5,519 | $13.59 |
| Hutter Christopher Gerald | A | Jun 10, 2026 | 4,231 | $13.59 |
| Rohen Jeremy | A | Jun 10, 2026 | 4,783 | $13.59 |
| Guy Henry L | A | Jun 10, 2026 | 4,783 | $13.59 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $177.9M | $74.9M |
| Gross Profit | - | $22.1M | $17.2M |
| Operating Income | - | -$5.1M | -$7.0M |
| Net Income | - | -$13.6M | $867K |
| Gross Margin | - | 12.4% | 23.0% |
| Op. Margin | - | -2.9% | -9.4% |
| Net Margin | - | -7.6% | 1.2% |
| Balance Sheet | |||
| Total Assets | $163.3M | $147.3M | $111.9M |
| Equity | $107.4M | $93.5M | $87.0M |
| ROE | - | -14.5% | 1.0% |
| Per Share | |||
| EPS | - | $-1.34 | $0.09 |
| Cash Flow | |||
| Operating CF | - | $14.7M | -$519K |
| CapEx | - | $1.9M | $1.5M |
Source: XBRL data in ASCENT INDUSTRIES CO. (ACNT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate ACNT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 19 | $27.3M |
| Q1 2026 | 21 | $30.5M |
| Q4 2025 | 18 | $39.3M |
| Q3 2025 | 17 | $30.0M |
| Q2 2025 | 15 | $28.3M |
| Q1 2025 | 14 | $18.1M |
| Q4 2024 | 9 | $14.6M |
| Q3 2024 | 7 | $8.1M |
- Morgan Stanley+33.5K (+44%)
- AQR Capital Management+22.4K (+79%)
- Citadel Advisors LLC+7.9K (+26%)
- FMR LLC (Fidelity)+257 (+26%)
- PNC Financial Services+138 (+115%)
- BlackRock−335.0K (-66%)
- State Street Corp−66.7K (-64%)
- Renaissance Technologies LLC−49.8K (-15%)
- Northern Trust−41.9K (-62%)
- Two Sigma Investments−34.8K (-26%)
- Millennium Management+94.9K
- Vanguard Portfolio Management LLC−47.5K
- Invesco Ltd−12.5K
- Citigroup−381
Source: 13F-HR filings on SEC EDGAR (aggregated from 120 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ACNT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 22, 2026 | - | - | - |
| 8-K | Aug 26, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 8-K | Jun 29, 2026 | - | Analysis | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 8-K | Jun 10, 2026 | - | Analysis | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 8-K | May 18, 2026 | - | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 4 | Apr 8, 2026 | - | - | - |
| 4 | Apr 6, 2026 | - | - | - |
| 8-K | Apr 1, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
Related Health Care companies
- PRM · Perimeter Solutions, Inc.Chemicals & Allied Products
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
ACNT SEC filings: frequently asked questions
Which institutions hold ACNT stock?
As of June 30, 2026, the largest ASCENT INDUSTRIES CO. (ACNT) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($5.2 million), Dimensional Fund Advisors ($4.3 million), Renaissance Technologies LLC ($4.2 million), Wells Fargo & Co ($3.1 million), BlackRock ($2.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ACNT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), ASCENT INDUSTRIES CO. (ACNT) reported revenue of $74.9 million (down 57.9% from FY2024) and net income of $867,000. Diluted EPS was $0.09. The figures come from the XBRL data in the 10-K.
What did ACNT report in its latest 8-K?
ASCENT INDUSTRIES CO. (ACNT) filed an 8-K on August 26, 2026 reporting Item 7.01 (Regulation FD Disclosure). Investor presentation scheduled for August 26, 2026, providing management’s latest investor messaging.
What are the latest ACNT SEC filings?
ASCENT INDUSTRIES CO. (ACNT) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on August 26, 2026 and a Form 4 insider filing on September 22, 2026.
What is ACNT's SEC CIK number?
ASCENT INDUSTRIES CO. (ACNT)'s SEC Central Index Key (CIK) is 95953. EDGAR lists every ACNT filing under that number.
Ask anything about ACNT
The research agent reads ACNT's filings, financials, insider trades and 13F holders, then answers with sources.